Belzutifan
PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC) . PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM) .
Product Specifications
CAS Number
1672668-24-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
383.34
Molecular Formula
C17H12F3NO4S
Notes
Research use only, not for human use.
Receptor
——
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1135314-01 0.02 mg (E-Coli)
Recombinant Synechocystis sp. UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF)
Ask
View Details 
MBS1135314-02 0.02 mg (Yeast)
Recombinant Synechocystis sp. UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF)
Ask
View Details MBS1135314-03 0.1 mg (E-Coli)
Recombinant Synechocystis sp. UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF)
Ask
View Details MBS1135314-04 0.1 mg (Yeast)
Recombinant Synechocystis sp. UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF)
Ask
View Details